Showing results (481-490 of 659) with videos related to

Sort By:
Pageof 66
The Lancet. Microbe|August 18, 2026
Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trialJane Metz, George Qian, Begonia Morales-Aza, et al.
The Lancet. Microbe|August 17, 2026
A WHO International Standard for neutralising antibodies to Chikungunya virus: development and evaluationSally A Baylis, Constanze Yue, Marcus Panning, et al.
The Lancet. Microbe|August 25, 2026
Genomic diversity of Trypanosoma cruzi clinical isolates: a retrospective analysisJill M C Hakim, Sneider Alexander Guiterrez Guarnizo, Angel Duran, et al.
The Lancet. Microbe|September 15, 2026
An updated list of actinomycetoma causative agents and their treatment responsesRihab A H Mohammed, Michiel L Bexkens, Wendy W J van de Sande
The Lancet. Microbe|September 29, 2026
Epidemiology and phylogenomic characterisation of the 2025 Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational studyTony Wawina-Bokalanga, John Otokoye Otshudiema, Richard Kitenge-Omasumbu, et al.
The Lancet. Microbe|September 30, 2026
MERS-CoV in Africa: a One Health review of the silent reservoirSherif A El-Kafrawy, Mai M El-Daly, Menatallah S El-Kafrawy, et al.
The Lancet. Microbe|February 21, 2025
How can the gut microbiome be targeted to fight multidrug-resistant organisms?Benjamin Davido, Blair Merrick, Ed Kuijper, et al.
The Lancet. Microbe|January 13, 2025
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection studyNavin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
The Lancet. Microbe|January 10, 2025
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trialNorbert Heinrich, Veronique de Jager, Julia Dreisbach, et al.
The Lancet. Microbe|January 19, 2025
Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort studyGabriel Heyman, Sofia Jonsson, Nikos Fatsis-Kavalopoulos, et al.
Pageof 66